Two different review studies identified correlations between lithium responders and serum levels of BDNF, describing that excellent lithium responders (patients in whom monotherapy prevented future episodes of BD for 10 or more years) maintained normal serum levels, even in the long term [41,42]. The gene discussed is BDNF; the disease is Behcet disease.